Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE) (NCT04623099)

🧪 Interventions in This Study

• Escitalopram (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience — Cincinnati, Ohio

📞 Contact the Study Coordinator

Phone: (513) 558-2866

Email: neptunza@uc.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Anxiety

• Intervention Trial for Healthcare Workers With Anxiety — Los Angeles, California
• Smartphones Aggravating Anxiety Symptoms — Rochester, Minnesota
• Digital Single Session Intervention for Youth Mental Health — Indianapolis, Indiana
• Testing FIRST in Youth Outpatient Psychotherapy — Cambridge, Massachusetts
• Novel Mental Health Therapies to Improve Military Readiness — Nellis Air Force Base, Nevada
• Brain Stimulation & Generalized Anxiety Study — New York, New York

Explore by condition: All Anxiety clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.